VIDA GLOBAL INC. financials

VIDA CIK 0001973062

Source: EDGAR filings · Built 2026-08-18T00:14:41Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026Q1 2026
EBITDA -1.28M -702.74K -209.82K -285.50K
Working Capital 14.21M 1.67M 2.43M
Net Debt -2.32M
Gross Margin 48.64% 52.13% -14.80% -112.71%
Operating Margin -453.46% -289.80% -454.38% -1140.38%
Net Margin -484.21% -363.44% -97.38% -1463.79%
Return on Equity (ROE) -9.05% -22.78% -2.17% -16.39%
Return on Assets (ROA) -8.64% -20.96%
Current Ratio 18.31× 4.95× 8.56×
Debt-to-Equity 0.00×
Cash Conversion Ratio 0.95× 0.70× 4.48× 0.37×
Accruals Ratio -0.00× -0.06×

Income Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026Q1 2026
Revenue from Contract with Customer, Excluding Assessed Tax 323.91K 306.03K 72.95K 35.66K
Revenues 323.91K 306.03K 72.95K 35.66K
Cost of Revenue 166.37K 146.49K 83.75K 75.86K
Selling, General and Administrative Expense 586.96K 231.17K 141.49K 110.71K
Operating Expenses 1.79M 1.19M 404.43K 442.36K
Operating Income (Loss) -1.47M -886.89K -331.48K -406.69K
Income Tax Expense (Benefit) 0
Net Income (Loss) Attributable to Parent -1.57M -1.11M -71.04K -522.03K
Earnings Per Share, Basic $-0.16 $-0.25 $-0.02 $-0.16
Weighted Average Number of Shares Outstanding, Basic 9.55M 4.43M 4.37M 3.20M
Earnings Per Share, Diluted $-0.16 $-0.25 $-0.02 $-0.16
Weighted Average Number of Shares Outstanding, Diluted 9.55M 4.43M 4.37M 3.20M

Balance Sheet

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026Q1 2026
Assets, Current 15.03M 2.10M 2.75M
Assets 18.16M 5.31M 6.15M
Liabilities, Current 821.05K 424.26K 321.60K
Liabilities 821.05K 424.26K 321.60K
Stockholders' Equity Attributable to Parent 17.34M 4.88M 5.82M 3.27M 3.19M 3.59M
Common Stock, Shares, Outstanding 0 6.08M 5.43M

Cash Flow Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026Q1 2026
Net Cash Provided by (Used in) Operating Activities -1.50M -777.82K -318.45K -194.03K
Net Cash Provided by (Used in) Investing Activities -328.48K -181.39K -230.65K -118.29K
Net Cash Provided by (Used in) Financing Activities 13.99M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (VIDA CIK 0001973062), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

GGROU

Golden Growers Cooperative

PMTS

CPI Card Group Inc.

ALLO

Allogene Therapeutics, Inc.